Deborah Ogbeni is studying for a PhD in Pharmacy toxicology and drug discovery at the School of Life and Medical Sciences, University of Hertfordshire. Deborah finished her undergraduate degree in Biomedical Sciences in (2014), and then initiated a Master by Research degree in Pharmacology in 2014.
Deborah converted her masters into a PhD in (2014) and is currently working with a supervisory team including Dr Louise S. Mackenzie, Dr Pryank Patel, Dr David Y.S. Chau, Dr Stewart Kirton, and Dr Sharon Rossiter, plus a collaborator at the Barts Cancer Insititute, Queen Mary University of London; Dr Tatjana Crnogorac-Jurcevic on a project which was originally funded by the charity Worldwide Cancer Research. She is currently improving and validating techniques to screen newly designed and synthesised compounds for their biological effects to inhibit pancreatic cancer cell progression, and isolating lead compounds that can be further developed for use as new therapies for pancreatic cancer.
Deborah is keen to expand and develop her research skills further within the fields of drug discovery and development to contribute to new innovative disease-targeted treatments.